Skip to main content
Image placeholder title

Drugs in Development for Advanced Pancreatic Cancer

BRCA, RAS, KRAS, NRG, ATM and other cancer causing mutations are being targeted with precision cancer medicines.

Pancreatic Cancer Connect is a unique resource that brings patients, caregivers, advocates and experts together in a single community where individuals benefit from a blend of expert-authored news and educational programming alongside a robust social network, providing insight into symptoms, diagnosis, treatment, and the support of other individuals being treated at some of the best cancer centers. Pancreatic Cancer Connect offers users expert authored clinically-reviewed information and the perspective of their peers in a safe, objective space, helping to ensure they become empowered in their healthcare journey.